Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

TYPHOID VI POLYSACCHARIDE VACCINE

Awarded
SPE2DP-26-T-4363Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract is for the procurement of 10 vials of Typhoid Vi Polysaccharide Vaccine, modified and acellular, each containing 10 mL and providing 20 doses, under NSN 6505-01-385-6328. The vaccine must comply with the Medical Procurement Item Description No. 3 dated March 20, 2006, with the specific modification that packaging must be in vials rather than boxes. It requires a shelf life of 18 months, non-extendable, with at least 15 months remaining at the time of delivery to the first government activity. The product must be shipped under strict constant refrigeration between 2°C and 8°C (36°F to 46°F). Packaging, marking, and labeling must adhere to MIL-STD-129 and the latest edition of the Medical Marking Standard No. 1, with barcoding that includes the NSN, lot number, and control number. Palletization must meet DLA Packaging Requirements for Procurement (RP001), and for non-hazardous material, commercial packaging must follow ASTM D3951, though DLA requirements take precedence. The item is to be delivered FOB destination to the USS RALPH JOHNSON DDG 114 at FPO AP 96691-3300, with a delivery window of five days after order issuance, which is scheduled for July 30, 2026, making the required delivery date July 31, 2026. The contract is a fixed-price, firm-fixed-price arrangement with a total value of $9,272.30 for 10 vials at $927.23 per vial. Inspection and acceptance occur at the destination, and invoicing must be submitted via Wide Area WorkFlow. All packaging and labeling must comply with DLA’s Master List of Technical and Quality Requirements. The contract incorporates multiple FAR and DFARS clauses, including those on combating trafficking in persons, employment eligibility verification, sustainable products, hazardous material identification, whistleblower rights, and NIST SP 800-171 assessment requirements, and includes waived provisions for equal opportunity for workers with disabilities. The offeror must provide a Unique Entity Identifier and CAGE code, and representations regarding small business status are required, though no socioeconomic set-asides are

General Info

Procure 10 vials of Typhoid Vi vaccine, 20 doses each, 18-month shelf life, refrigerated, FOB destination, deliver to USS RALPH JOHNSON by July 2026.

Contract Value

$9,201.2

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

AP, USA

Set-Aside

NONE

Award Issued Date

Documents

2

Delivery Order SPE2DP-26-V-0857 for Typhoid VI Polysaccharide Vaccine

PDF, High priority: read this firstdelivery-order
High

RFQ SPE2DP-26-T-4363 Medical Supply Chain

PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Solicitation

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
Contacts1 person available
OfficeUSA
Office AddressUSA

Full Description

Show more
DLA award SPE2DP26V0857 posted on DIBBS. Awardee: MR UNLIMITED, LLC (CAGE 3W8H0) Total Contract Price: $9,201.20 Award Date: 08-04-2026 Solicitation: SPE2DP-26-T-4363 Line items: - TYPHOID VI POLYSACCHARIDE VACCINE (NSN/Part 6505013856328, PR 7017660319)

Similar Contracts

Same NAICS industry code

NAICS: 325414
New
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposal issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an unrestricted, IDIQ contract focused on Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC). The scope of work includes the purchase and storage of VAC, the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract features a ceiling price of 800 million dollars and a long-term performance horizon, consisting of five one-year ordering periods for VAC and direct purchases starting December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The contractor is required to produce VAC with a minimum capacity of 1.0 million doses and maintain storage on their premises under strict quality control and temperature monitoring standards. Due to the nature of the material, live FMDV is classified as a Tier 1 Select Agent, requiring specific authorization from the CDC/APHIS and adherence to rigorous shipping and security restrictions. Award will be based on the most advantageous offer, evaluating technical capability, past performance, and price, with technical and past performance factors weighted equally. Proposals must be submitted electronically in four separate volumes by November 10, 2026.
Mrpbs Minneapolis Mn

POSTED

2 days ago

DEADLINE

in 13 days
View Details
NAICS: 325414
DIBBS
JAPANESE ENCEPHALIT
Solicitation # SPE2DP-26-R-0001
Solicitation SPE2DP-26-R-0001 is a sole source, firm-fixed price, indefinite delivery, indefinite quantity contract issued by the Defense Logistics Agency for the procurement of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, in single-dose prefilled syringes. The contract has an eighteen month base term with estimated quantities ranging from a minimum of 277,760 to a maximum of 394,240 units. All products must be FDA approved, serialized according to the Drug Supply Chain Security Act, and manufactured in accordance with Medical Procurement Item Description Number 5. Deliveries are designated as FOB Destination to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, and must be completed within 120 days after the date of order. The successful offeror must demonstrate FDA approval or provide a manufacturer commitment letter ensuring supply availability and fixed pricing for the life of the contract. Proposals must be submitted electronically via the DLA Internet Bid Board System by November 6, 2026. Strict adherence to Medical Marking Standard No. 1D is required, specifically regarding cold chain storage between 2 and 8 degrees Celsius and detailed waterproof marking for exterior containers. Contract administration, including payment requests and receiving reports, will be managed through the Wide Area Workflow system. Award will be based on the most advantageous offer considering price, FDA approval, and agreement to all solicitation terms.
Defense Logistics Agency

POSTED

23 days ago

DEADLINE

in 8 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS